Park Avenue Securities LLC Seagen Inc. Transaction History

Park Avenue Securities LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$191.51 - $216.16 $539,292 - $608,706	2,816 New	2,816 $597,000
Q4 2022 Jan 24, 2023	BUY	$117.37 - $139.17 $35,915 - $42,586	306 Added 6.93%	4,722 $0
Q3 2022 Nov 01, 2022	SELL	$135.27 - $180.11 $2,705 - $3,602	-20 Reduced 0.45%	4,416 $604,000
Q2 2022 Jul 27, 2022	BUY	$108.81 - $179.33 $151,354 - $249,448	1,391 Added 45.68%	4,436 $785,000
Q1 2022 Apr 29, 2022	BUY	$119.61 - $157.85 $29,184 - $38,515	244 Added 8.71%	3,045 $439,000
Q4 2021 Apr 08, 2022	BUY	$142.57 - $190.86 $73,423 - $98,292	515 Added 22.53%	2,801 $433,000
Q3 2021 Oct 21, 2021	BUY	$142.45 - $169.82 $37,464 - $44,662	263 Added 13.0%	2,286 $388,000
Q2 2021 Aug 05, 2021	BUY	$135.08 - $161.1 $12,832 - $15,304	95 Added 4.93%	2,023 $319,000
Q1 2021 Apr 28, 2021	BUY	$137.51 - $190.8 $265,119 - $367,862	1,928 New	1,928 $268,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Park Avenue Securities LLC with notifications on news.